Cargando…
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.
We have used primary endocrine therapy for 61 elderly women with operable breast cancer (median age 77 years). Eleven patients (18%) had complete and 24 (39%) partial tumour regression, 12 (20%) had stable disease for a minimum of six months and 14 (23%) no response. Salvage surgery was undertaken i...
Autores principales: | Nicholson, S., Halcrow, P., Sainsbury, J. R., Angus, B., Chambers, P., Farndon, J. R., Harris, A. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246869/ https://www.ncbi.nlm.nih.gov/pubmed/3224082 |
Ejemplares similares
-
Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.
por: Nicholson, S., et al.
Publicado: (1991) -
Epidermal growth factor receptor status of histological sub-types of breast cancer.
por: Sainsbury, J. R., et al.
Publicado: (1988) -
Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989) -
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
por: Wright, C., et al.
Publicado: (1992) -
pNR-2/pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response.
por: Henry, J. A., et al.
Publicado: (1991)